News, Policy & Media


Chief Brexit negotiator outlines the UK's position ahead of next month's talks.

David Frost, the PM's Europe Adviser and Head of Taskforce Europe, set out the key themes of the UK's negotiating position during a speech at the Université Libre de Bruxelles on 17 February. 

The main takeaway from Mr Frost's talk is that the UK will not accept regulatory alignment with the EU. He noted that the point of Brexit would "be defeated" if the EU maintained some supervisory oversight over the setting of British standards. This is a position that "will not move under pressure", despite overtures from the EU, which wants to see a 'level playing field' that will ensure fair and open competition. Brussels also envisages a future where the European Court of Justice has a part to play in regulating the terms of the UK's future relationship with the EU. 

Mr Frost reiterated recent rhetoric from the PM which sets out the UK's ambition to secure a Canadian-style comprehensive free trade agreement: failure to secure this will result in the UK trading with the EU on World Trade Organisation Most Favoured Nation (MFN) terms, a relationship that is being referred to as an 'Australian-style agreement.'

He also said that the UK will not extend the transition period past its current deadline of 31 January 2020. 

More details from both the UK and EU are expected in the coming week, before both sides get down to business in early March. 



Please find attached  and below some further information regarding export health certificates f...

Read More >

Please see below a presentation with two useful organograms which illustrate the Test and Trace...

Read More >

Yesterday the National Audit Office has published two reports: NHS financial management and sustaina...

Read More >

Following on from the latest HMG webinar, officials have put together an FAQ answering questions rai...

Read More >

Early detection of cancer must be heavily invested in according to Cancer Research UK’s new re...

Read More >

The trade section of the Office for Life Sciences has published a comprehensive Q&A document, in...

Read More >